Qualitative & Quantitative Composition

Each 5 ml contains extracts of picrorhiza kurroa 12.5mg, andrographis paniculata 2.5mg, phyllanthus amarus 2.5mg, boerrhavia diffusa 5mg, azadirachata indica 0.9mg, emblica officinalis 4.2mg, terminalia chebula 1mg, terminalia belerica 0.4mg, eclipta alba 3.1mg, zingiber officinale 10mg, and piper longum 5.2mg. In flavored syrup base.

Dosage Form

Oral Liquid

Therapeutic indications

Health enhancer and liver tonic.

Dosage and administration

• Below 12 years – 1 Tsf T.D.S.
• Above 12 years (For treatment of liver disorders) – 2 Tsf T.D.S.
• Above 12 years (For prevention of liver disorders) – 2 Tsf B.D.S.

As directed by physician

Clinical trials / Scientific findings of Hepatogard

The Indian Practitioner, Vol. XLVl, Feb 1993, No. 2, PP. 141-151, Clinical trial of hepatogard in acute viral hepatitis.

The Bombay Hospital Journal, Vol.34, No. 4, 1992, PP. 35-40, Effect of prophylactic Hepatogard treatment on the incidence of hepatotoxicity in patients receiving anti – tuberculosis drugs.

Contra-indications

None except hypersensitivity to the ingredients.

Warnings and Precautions

Dosage should be taken as per directed by physician

Drug interactions

None reported

Pregnancy & lactation

None effect observed

Undesirable effects/side effects

None reported